# ALYFTREK

NDC: 51167-121
Generic name: vanzacaftor, tezacaftor, and deutivacaftor
Labeler / Manufacturer: Vertex Pharmaceuticals Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20241220

FDA application: NDA218730

## Active ingredients

- DEUTIVACAFTOR: 125 mg/1
- TEZACAFTOR: 50 mg/1
- VANZACAFTOR: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51167-121"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51167-121
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7e635909-c6fd-4f0d-ae77-cdff03653a20